Open tender · Germany · Contract notice
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Acetylsalicylsäure (B01AC06) im Rahmen eines sogenannten Open-House-Modells.
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse in Germany is inviting bids for “Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Acetylsalicylsäure (B01AC06) im…”. Bids close on 30 November 2026.
The work
Conclusion of non-exclusive discount contracts for acetylsalicylic acid (B01AC06) drugs from 01.02.2025 to 31.01.2027 under an open-house model.
- Contracts are non-exclusive and offered to all market participants
- Excludes pediatric medicines per BfArM list
- Drug must be approved and market-ready in Germany
- Proof of marketability via Lauer-Taxe or AMIce database extracts required
Key facts
- Contract period
- up to 24 months per contract
What it takes to qualify
Worth a closer look
- This is a contract notice for a public procurement under the SGB V framework, not a standard tender for goods or services.
- The document states it is not a public contract under the EU procurement directive, but a contract notice for transparency purposes.
Policy conditions
No reservation, preference or local-content restriction.